Report of adverse events of special interest (AESIs) for sintilimab plus a bevacizumab biosimilar (IBI305) in unresectable hepatocellular carcinoma. A multicenter study to investigate the role of ...
Sharrow Engineering is leveraging advanced 3D sand-casting techniques as it scales production of its patented Sharrow ...
The U.S. Army’s Capability Program Executive Ammunition and Energetics (CPE A&E), headquartered at Picatinny Arsenal, NJ, is ...
Touchstone Advanced Composites, part of the Innovations business unit of Core Natural Resources, completed a major expansion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results